Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD, discuss the use of beta-blocker therapy following acute MI ...

The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study ...

The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study ...

The following is a summary of “Angiography-versus wire-based microvascular resistance index to detect coronary microvascular ...

In a recent study, researchers explored the association between HCQ and the overall risk of CV events in people with SLE.

If you’ve experienced a heart attack, your healthcare provider may prescribe certain medications to help prevent one from ...

Cardiovascular events are not significantly decreased with edetate disodium chelation in patients with CAD and history of myocardial infarction and diabetes.

The following is a summary of “Healthcare Resource Utilization Following Acute Myocardial Infarction Findings from RECORD-MI ...

Tumour necrosis factor-alpha (TNF-a) is a cytokine. A cytokine is a small protein. TNF-a is involved in inflammation. Drugs such as infliximab, etanercept, and adalimumab inhibit TNF activity and ...

JPI-289 is under clinical development by Jeil Pharmaceutical and currently in Phase II for Myocardial Infarction.

The benefits of complete revascularization over culprit-only coronary artery revascularization were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and ...

Personality traits can influence cardiovascular disease (CVD) risk with type 2 diabetes mellitus (T2DM), according to a study.